D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 43 Citations 10,222 82 World Ranking 3351 National Ranking 35

Overview

What is he best known for?

The fields of study he is best known for:

  • Virus
  • Cancer
  • Immune system

Reinhard Kirnbauer focuses on Virology, Molecular biology, Antibody, Papillomaviridae and Bovine papillomavirus. The various areas that Reinhard Kirnbauer examines in his Virology study include Epitope and Immunology. Reinhard Kirnbauer has researched Epitope in several fields, including Virus and Virus-like particle.

The concepts of his Molecular biology study are interwoven with issues in Cell culture, Keratinocyte, Cytokine, Capsid and Cytotoxic T cell. Antibody and Adjuvant are commonly linked in his work. His study explores the link between Bovine papillomavirus and topics such as Immunization that cross with problems in Immunoglobulin G.

His most cited work include:

  • Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. (968 citations)
  • Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. (631 citations)
  • Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. (591 citations)

What are the main themes of his work throughout his whole career to date?

Virology, Immunology, Antibody, Epitope and Molecular biology are his primary areas of study. Virology is closely attributed to Bovine papillomavirus in his research. His work in Bovine papillomavirus addresses issues such as Papillomaviridae, which are connected to fields such as Hemagglutination.

His study in Antibody is interdisciplinary in nature, drawing from both In vitro, Virus-like particle and Immune system. His Epitope research is multidisciplinary, relying on both Monoclonal antibody, Immunogenicity and Pseudovirion. Reinhard Kirnbauer combines subjects such as Infectivity, Cell culture, Antiserum and Cytokine with his study of Molecular biology.

He most often published in these fields:

  • Virology (55.04%)
  • Immunology (35.66%)
  • Antibody (41.09%)

What were the highlights of his more recent work (between 2013-2021)?

  • Virology (55.04%)
  • Antibody (41.09%)
  • Immunology (35.66%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Virology, Antibody, Immunology, Vaccination and Epitope. His Virology research integrates issues from Chimeric virus and Immunogenicity. His Antibody research includes themes of In vitro and Virus-like particle.

His biological study spans a wide range of topics, including Bovine papillomavirus and Disease. His Vaccination study incorporates themes from Virus and Pseudovirion. Reinhard Kirnbauer focuses mostly in the field of Epitope, narrowing it down to matters related to Capsid and, in some cases, Cell culture and Sf9.

Between 2013 and 2021, his most popular works were:

  • Developments in L2-based human papillomavirus (HPV) vaccines. (34 citations)
  • Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types. (30 citations)
  • Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studies. (30 citations)

In his most recent research, the most cited papers focused on:

  • Virus
  • Cancer
  • Immune system

Reinhard Kirnbauer mainly investigates Virology, Antibody, Papillomavirus Vaccines, Epitope and Vaccination. His research in Virology intersects with topics in HPV infection and Immunology, Antigen, Immunogenicity. His HPV infection research includes elements of Papillomaviridae, Saliva and Immunoglobulin G.

The concepts of his Antigen study are interwoven with issues in Cervical cancer, Virus-like particle, Fusion protein and Pseudovirion. His work in Immunogenicity covers topics such as Adjuvant which are related to areas like Titer, Serotype, Heterologous, Immune system and Bovine papillomavirus. His studies deal with areas such as Neutralization and Capsid as well as In vitro.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

R Kirnbauer;F Booy;N Cheng;D R Lowy.
Proceedings of the National Academy of Sciences of the United States of America (1992)

1336 Citations

Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light.

A Köck;T Schwarz;R Kirnbauer;A Urbanski.
Journal of Experimental Medicine (1990)

989 Citations

Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles.

Reinhard Kirnbauer;Janet Taub;Heather Greenstone;Richard Roden.
Journal of Virology (1993)

814 Citations

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

F Breitburd;R Kirnbauer;N L Hubbert;B Nonnenmacher.
Journal of Virology (1995)

687 Citations

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

Heather L. Greenstone;John D. Nieland;Karin E. de Visser;Marloes L. H. De Bruijn.
Proceedings of the National Academy of Sciences of the United States of America (1998)

432 Citations

A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.

Reinhard Kirnbauer;Nancy L. Hubbert;Cosette M. Wheeler;Thomas M. Becker.
Journal of the National Cancer Institute (1994)

429 Citations

Virus-like Particles of Bovine Papillomavirus Type 4 in Prophylactic and Therapeutic Immunization

R. Kirnbauer;L.M. Chandrachud;B.W. O'neil;E.R. Wagner.
Virology (1996)

396 Citations

In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.

Richard B.S. Roden;Heather L. Greenstone;Reinhard Kirnbauer;Frank P. Booy.
Journal of Virology (1996)

371 Citations

Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses.

Saeed Shafti-Keramat;Alessandra Handisurya;Ernst Kriehuber;Guerrino Meneguzzi.
Journal of Virology (2003)

325 Citations

Ultraviolet light induces increased circulating interleukin-6 in humans.

Agatha Urbanski;Thomas Schwarz;Peter Neuner;Jean Krutmann.
Journal of Investigative Dermatology (1990)

292 Citations

Best Scientists Citing Reinhard Kirnbauer

Joakim Dillner

Joakim Dillner

Karolinska University Hospital

Publications: 134

John T. Schiller

John T. Schiller

National Institutes of Health

Publications: 129

Neil D. Christensen

Neil D. Christensen

Pennsylvania State University

Publications: 96

Richard B.S. Roden

Richard B.S. Roden

Johns Hopkins University

Publications: 79

Douglas R. Lowy

Douglas R. Lowy

National Institutes of Health

Publications: 70

Ian H. Frazer

Ian H. Frazer

University of Queensland

Publications: 68

Matti Lehtinen

Matti Lehtinen

Karolinska Institute

Publications: 62

Michael Pawlita

Michael Pawlita

German Cancer Research Center

Publications: 54

Martin Müller

Martin Müller

German Cancer Research Center

Publications: 46

Tim Waterboer

Tim Waterboer

German Cancer Research Center

Publications: 44

Kathrin U. Jansen

Kathrin U. Jansen

Pfizer (United States)

Publications: 40

W. Martin Kast

W. Martin Kast

University of Southern California

Publications: 39

Lutz Gissmann

Lutz Gissmann

German Cancer Research Center

Publications: 38

Jorma Paavonen

Jorma Paavonen

University of Helsinki

Publications: 36

Edward P. Rybicki

Edward P. Rybicki

University of Cape Town

Publications: 36

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.